, et al.. Opinion about seasonal influenza vaccination among the general population 3 years after the A(H1N1)pdm2009 influenza pandemic. Vaccine, Elsevier, 2015, 33 (48) Study design:The study was conducted using data collected from 5374 participants during the 2012/2013 season of the GrippeNet.fr study. The opinion about seasonal influenza vaccination was studied on three levels ("positive", "negative" or "neutral"). The link between the participant's characteristics and their opinion regarding the seasonal influenza vaccination were studied using a multinomial logistic regression with categorical variables. The "positive" opinion was used as the reference for identifying individuals being at risk of having a "neutral" or a "negative" opinion.
Introduction
According to the World Health Organization(WHO), seasonal influenza is a major cause of morbidity and mortality worldwide, and is responsible for 3 to 5 million serious illnesses and for 250,000 to 500,000 deaths each year, depending on virulence and epidemic duration (1) . In France, influenza is the reason for 700,000 to 4.8 million influenza-like-illnesses (ILI) consultations each year, which represents 1to 8 % of the general population (2, 3) , and 0.3 (± 0.6) to 4 (± 2.8) work days lost per person and per influenza episode (4) . Mortality is difficult to estimate because it includes influenza related deaths, but also deaths recorded for other reasons such as "pneumonia" or "cardiovascular diseases" (5) . Thus, it is estimated from 0 to 24 deaths per 100,000 inhabitants and per flu epidemic from 1972 to 2010 (6) , whereindividualsaged over 65 accounted for 90% of deaths (7, 8) .
Vaccination isthe main preventive measure advocated by the WHOagainst influenza. In France vaccination is recommended for individuals at risk of developing complicated forms of diseases likeindividuals over age 65, pregnant women, obese individuals, healthcare workers, and individuals living with a chronic disease for 6 months or more (9) . Vaccination of these groups remains a major public health concern withthe objective to reachan immunization coverage of 75% in 2015 (10) .
The vaccination campaign management during the 2009 influenza pandemic A(H1N1) appears to have strongly affected the acceptability of vaccination among the French population, particularly vaccination against seasonal influenza. During the pandemic, several studies wereconductedin France to assessperceptions of the A(H1N1)pdm09 vaccine in the general population (11) , as well as among health professionals (12) (13) (14) (15) . The main results revealedexistingdoubts aboutthe severity of the pandemic, the safety and efficacy of thevaccine adjuvant, and the role of the physician in 5 patients' adherence to the vaccination. Similar results were also obtained in other countries (16- In view of the aforementioned data,the objectivesof this study were to assess theseasonal influenza vaccine acceptability among the general population and factors associated with this acceptability, three years after the 2009 pandemic.
Materials and methods
The study was conducted using data collected inthe cohort GrippeNet.fr, a web-based participative study conducted in France (25) .Developed by the French National Institute of Health and Medical Research (Inserm), Pierre and Marie Curie University (UPMC) and the French Institute for Public Health Surveillance (InVS), this project is part of a broader European study,Influenzanet (http://www.influenzanet.eu) (26) , whichallows monitoring ILI evolution directly in the general population.The inclusion criteria to participate in the GrippeNet.fr study include: 1) residency in France 2) comprehension of the French language 3) access to the Internet. Upon registration, participants were asked to complete a baseline questionnaire covering demographic factors (age, gender), geographicalfactors (location of home and work/school expressed at themunicipality level), socio-economic factors (household size and composition, occupation, educational level, number of daily contacts with groups of patients, children or elderly, daily transportation means), 6 and health-related factors (height and weight, diet, vaccination status, pregnancy status, smoking habits,major risk conditions, and opinion about seasonal influenza vaccination evaluated over three levels ("positive", "negative" or "neutral").Subsequently, they were invited to describe weekly clinical symptoms during the flu season. From November 2012 to April 2013, 6059
individualsin France voluntarily contributed to the data collection for GrippeNet.frThe representativeness of the participants was recently published elsewhere (25) .The GrippeNet.fr population was not representative of the general population in terms of age and gender, however all ageclasses were represented, including the older classes (65+ years old), generally less familiar with the digital world, butconsidered at higher risk for influenza complications. Once adjusted on demographic indicators, the GrippeNet.fr populationwas found to be more frequently employed, with a higher education level and vaccination rate with respect to the generalpopulation. A similar propensity to commute for work to different regions was observed, and no significant difference wasfound for asthma and diabetes. This amounts to 5374 of the 6059 GrippeNet.fr participants; 659 children, 19 persons who didn't specify their ages,and 7 persons living outside Francewere excluded from the study.
Study population

Data analysis
A description of the population included in the study was conducted and outlierswereverified, corrected or excluded as needed.The opinion about seasonal influenza vaccinationwas studied usingthe three levels proposed in the baseline questionnaire ("positive", "negative" or "neutral").The link between the participant'scharacteristics and their opinion regarding the seasonal influenza vaccination was studied using a multinomial logistic regressionwith categorical 7 variables. The "positive"opinionserved asthe reference foridentifyingindividualsbeing at risk of having a "neutral" or a "negative" opinion. Explanatory variables included socio-demographic characteristics (age, sex, educational level, main activity, presence of children in the household), contacts during a typical day (children, old individuals, sick individuals); geographical characteristics (place of residence)and clinical characteristics. According to the national French recommendations (9), anew variable named "At risk group for influenza" was created, defined by individuals with at least one of the following characteristics: age ≥ 65 years, body mass index (BMI) ≥ 40, pregnancy or having received aninfluenza vaccination voucher from the French government, which include patients with a chronic underlying disease. The effect of each explanatory variable was studied using univariateanalysesfirst, then multivariate analyses.
Allvariables that had a p-value less than 0.2 in univariate analyses were included in the multivariate analyses. In multivariate analysis, two variables were deliberately excluded: the vaccination status variableand the variable dealing with individuals being at risk of having complicated influenza,as they were too correlatedwith the other variables of interest. Each odds ratiowas obtained from a step down multinomial logistic regression with categorical variables, using a 95% confidence interval. All statistical analyses were performed using the R software.
Results
Population's characteristics
The study population consisted of 2018 men (38%) and 3356 women (62%), with amean age of50 years (Table 1) . For the educational level,1569 participants (37%) had at least a Masters degree and664 participants (16%) had an educational level below theBachelorsdegree. Regarding employment, 2300 participants (43%) were employedfull-timeand 1417 (26%) were retired. All regions were represented.Most participants were living in medium size urban cities: 1373 persons (25.5%) lived in cities with 2,000 to 10,000 habitants and 1833 (34%) in cities with10,000 to 8 100,000 inhabitants. Vaccination coverage against seasonal influenza was estimated to be28% (n=1515) in the study population. Among the participants, 1636 (31%) had at least one risk factor for complicated influenza and among them, 897 (55%) were vaccinated against influenza.
Opinion regarding influenza seasonal vaccinationand associated factors
In our study, 2037 participants (39%) had a positive opinion regardinginfluenza seasonalvaccination, 2052 participants (39%) had a neutral one and 1167 participants (22%) a negative one. Among individuals≥ 65 years old, 554 (55%) had a positive opinion regarding influenza seasonal vaccination, 273 (27%) had a neutral one and 179 (18%) a negative one.
In multivariate analysis (Tables 2a-2b 
Discussion
This work provides an overview of the opinions about influenza seasonal vaccination in the general population using data from GrippeNet.fr study, as well as factors related to a negative or neutral opinion of thisvaccination.
In the study, almost a quarter of participants reported a negative opinion of influenza seasonal vaccination and 39% a neutral one. To our knowledge, few studies haveaddressed the question of opinions onvaccination against the seasonal flu. Most studies addressvaccination acceptability based onimmunization coverage rates of: healthcare workers (12, 27, 28) , individualstargeted by the recommendations (29) (30) (31) or the general population (28, 32, 33) . In (35) . This decrease in the flu vaccination coverage rates is also observed in Spain (27) , Switzerland (36), Germany (37), whereasthe situation is more nuanced in the UK (38) . In the United States an isolated decrease of the vaccination coverage rate was observed among adults in 2011/2012 (39) .
In this study, we highlighted factors associated with opinion on flu vaccination for the general population and not only on at risk individuals currently targeted by recommendations. It allowsoutlining theprofiles linked with neutral or negative opinion regardingflu vaccination.
Individualsmore inclined to have neutral or negative opinions were healthy young adults, those preferring homeopathy and those who did not work in contact with elderly or sickindividuals. This profile appeared similar to those of parents of children from 6 to 59 months of age targeted by the most recent WHO flu vaccine recommendations (40) , independently of the fact that children may be at risk of complication. This suggeststhat it may be difficult to implement such a measure in France. In Europe, only Finland has implemented a vaccination program for young children, the UK planned to do the samefor children ages2-17 years old (41) . Other countries, like the United States, recommend the vaccination of the entire population from 6 months of age (42) . Even if the immunization schedule was simplified in 2013 in France (9) ,it stillprovides a large number of vaccinations in young children. The addition of a new yearly vaccine against influenza in this age groupseems to be particularly difficult.
Individuals with a severe obesityhad a more frequently negative opinion of the influenza vaccine, even though they have been targeted by the vaccine recommendations since 2010 (Notice HCSP 29/12/2010). This resistance towards theinfluenza vaccination is confirmed by a lowvaccination coverage ratein this group (around 25%) (43) . It is difficult for the NationalHealth Insurance to obtain theBMI of patients in orderto send them a vaccination voucher and appropriate information.
Health professionals and the media are, as a result, responsible for vaccinationpromotion. 11 However, when looking at the posters and leaflets of the last immunization campaigns (44) (45) (46) , we observed that the focus was primarily on the elderly and patients with chronic diseases. Obese individuals are mentioned in several documents, but are not directly targeted by these campaigns.
The results of the study also suggestthat information on the influenza vaccine should be targeted more widelynot restricting it only to individuals at risk, but also considering social characteristics for example,students, as already successfully tested in the USA (47) 
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